Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00427336 · ClinicalTrials.gov registry record · NA
Purine Analog-Based Conditioning in Patients With Severe Aplastic Anemia
A NA study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT00427336: Completed NA study, sponsored by M.D. Anderson Cancer Center.
NCT00427336 is a NA study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 9 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00427336, a NA study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
Primary Objectives: 1. To determine the feasibility and toxicity of employing purine-analog based conditioning for allogeneic donor stem cell transplantation in patients with severe aplastic anemia (AA). 2. To determine the engraftment kinetics and degree of chimerism that can be achieved with this strategy.
Interventions
- DRUG Cyclophosphamide
- DRUG Fludarabine
- DRUG Antithymocyte Globulin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2000-12 |
| Est. Completion | 2009-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00427336
The ClinicalTrials.gov registry entry for NCT00427336 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Cyclophosphamide is the first listed.
NCT00427336 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00427336 about?
NCT00427336 is a clinical study titled "Purine Analog-Based Conditioning in Patients With Severe Aplastic Anemia". Primary Objectives: 1. To determine the feasibility and toxicity of employing purine-analog based conditioning for allogeneic donor stem cell transplantation in patients with severe aplastic anemia (AA). 2. To determine the engraftment kinetics and degree of chimerism that can be achieved with this...
What is the current status of trial NCT00427336?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2000-12. Estimated completion is 2009-08.
What interventions are being tested in trial NCT00427336?
The interventions under investigation include: Cyclophosphamide (DRUG), Fludarabine (DRUG), Antithymocyte Globulin (DRUG).
Who is sponsoring clinical trial NCT00427336?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.